You just read:

Ardelyx Announces Peer-Reviewed Publication of Positive Phase 3 Results of Tenapanor for the Treatment of Hyperphosphatemia in the Journal of the American Society of Nephrology

News provided by

Ardelyx

Mar 07, 2019, 17:00 ET